Using Circulating Tumor DNA-Based Molecular Residual Disease Detection for Postoperative Monitoring in Early-Stage Uterine Cancer. - Ketch PW; Scalise CB; Recio F; Berman T; Hook N; Loar P; Arend R; Dutta P; Gentry ZL; Kalashnikova E; Malhotra M; Liu MC; et al. (JCO precision oncology, 2025)